U.S. MARKETS FOR ONCOLOGY-RELATED DIAGNOSTIC ULTRASOUND, MINIMALLY INVASIVE BIOPSY, AND TISSUE SCREENING PRODUCTS

261 Pages | 38 Exhibits | 2014 Analysis | Forecasts Through 2017

OVERVIEW:
Cancer is the second-leading cause of death in the United States (U.S.) after heart disease. It is estimated that nearly 1.7 million people in the country will be diagnosed with cancer in 2014, and that approximately 585,720 will die from the disease. In the fight against cancer, diagnostic ultrasound imaging, minimally invasive biopsy, and tissue screening are among the methods that allow physicians to detect malignancies at their earliest and most treatable stages.

In 2012, approximately 92.0 million oncology-related diagnostic ultrasound, minimally invasive biopsy, and tissue screening procedures were performed in the U.S. Together, these procedures generated approximately $1.1 billion in corresponding product sales; it is expected that during the forecast period covered by this report, sales of diagnostic ultrasound, minimally invasive biopsy, and tissue screening products for oncology-related indications will increase at a compound annual rate of 3.9%, reaching nearly $1.4 billion in the year 2017.

This dynamic, new report from Medtech Insight includes analyses of products, current/forecast markets, competitors, and opportunities in the U.S. diagnostic ultrasound, minimally invasive biopsy, and tissue screening products arena.

Covered topics in this report include an overview of cancer in the U.S. including discussions of the different forms of the disease; automated and semi-automated tissue screening technologies; capacitive micromachined ultrasonic transducers; contrast-enhanced ultrasound; core needle biopsy systems; diagnostic ultrasound systems; Doppler and tissue harmonic imaging; fine-needle aspiration; human papilloma virus testing systems; minimally invasive biopsy; Papanicolaou smear testing systems; photoacoustic imaging; risk factors for cancer development; statistics covering new cancer cases, cancer prevalence, and cancer-related deaths; tissue elastography; and vacuum-assisted biopsy systems; among others.

TABLE OF CONTENTS:
EXECUTIVE SUMMARY

i. New Cancer Cases, Cancer Prevalence, and Deaths Due to Cancer 
ii. Oncology-Related Diagnostic Ultrasound, Minimally Invasive Biopsy, and Tissue Screening Procedures 
iii. Oncology-Related Diagnostic Ultrasound, Minimally Invasive Biopsy, and Tissue Screening Products 
	a. Oncology-Related Diagnostic Ultrasound Systems Market Segment 
	b. Minimally Invasive Biopsy Systems Market Segment 
	c. Tissue Screening Systems Market Segment 
iv. Methodology 

Exhibit ES-1: Estimated New Cases, Prevalence,and Deaths for Selected Types of Cancer 
Exhibit ES-2: Oncology-Related Diagnostic Ultrasound,Minimally Invasive Biopsy, and Tissue Screening, Combined Procedure Volumes Forecast, 2012-2017 
Exhibit ES-3: Oncology-Related Diagnostic Ultrasound, Minimally Invasive Biopsy, and Tissue Screening Products, Combined Market Forecast, 2012-2017 
Exhibit ES-4: Oncology-Related Diagnostic Ultrasound Systems,  Market Forecast, 2012-2017 
Exhibit ES-5: Minimally Invasive Biopsy Products, Market Forecast, 2012-2017 
Exhibit ES-6: Tissue Screening Products, Market Forecast, 2012-2017 

1. CANCER STATISTICS UPDATE

1.1 Acquired Capabilities of Cancer Cells 
1.2 Cataloging Genomic Alterations Involved in the Development of Cancer 
1.3 Risk Factors Associated with the Development of Cancer 
1.4 Cancer Staging 
1.5 New Cancer Cases, Cancer Prevalence, and Deaths Due to Cancer 
1.6 Clinical and Statistical Data for Selected Types of Cancer 
	1.6.1 Brain and Other Nervous System Cancers 
		1.6.1.1 Etiology 
		1.6.1.2 Epidemiology 
	1.6.2 Breast Cancer 
		1.6.2.1 Etiology 
		1.6.2.2 Epidemiology 
	1.6.3 Colorectal Cancer 
		1.6.3.1 Etiology 
		1.6.3.2 Epidemiology 
	1.6.4 Kidney/Renal Pelvis Cancer 
		1.6.4.1 Etiology 
		1.6.4.2 Epidemiology 
	1.6.5 Leukemia 
		1.6.5.1 Etiology 
		1.6.5.2 Epidemiology 
	1.6.6 Lung/Bronchus Cancer 
		1.6.6.1 Etiology 
		1.6.6.2 Epidemiology 
	1.6.7 Lymphoma 
		1.6.7.1 Etiology 
		1.6.7.2 Epidemiology 
	1.6.8 Melanoma 
		1.6.8.1 Etiology 
		1.6.8.2 Epidemiology 
	1.6.9 Oral Cavity and Pharyngeal Cancers 
		1.6.9.1 Etiology 
		1.6.9.2 Epidemiology 
	1.6.10 Ovarian Cancer 
		1.6.10.1 Etiology 
		1.6.10.2 Epidemiology 
	1.6.11 Pancreatic Cancer 
		1.6.11.1 Etiology 
		1.6.11.2 Epidemiology 
	1.6.12 Prostate Cancer 
		1.6.12.1 Etiology 
		1.6.12.2 Epidemiology 
	1.6.13 Thyroid Cancer 
		1.6.13.1 Etiology
		1.6.13.2 Epidemiology 
	1.6.14 Urinary Bladder Cancer 
		1.6.14.1 Etiology 
		1.6.14.2 Epidemiology 
	1.6.15 Uterine Cancer 
		1.6.15.1 Etiology 
		1.6.15.2 Epidemiology 

Exhibit 1-1: Estimated New Cases, Prevalence, and Deaths for Selected Types of Cancer 
Exhibit 1-2: Brain and Other Nervous System Cancers, Facts And Figures 
Exhibit 1-3: Breast Cancer, Facts And Figures 
Exhibit 1-4: Colorectal Cancer, Facts And Figures 
Exhibit 1-5: Kidney/Renal Pelvis Cancers, Facts And Figures 
Exhibit 1-6: Leukemia, Facts and Figures 
Exhibit 1-7: Lung/Bronchus Cancer, Facts And Figures 
Exhibit 1-8: Hodgkin Lymphoma, Facts and Figures 
Exhibit 1-9: Non-Hodgkin Lymphoma, Facts and Figures 
Exhibit 1-10: Melanoma of the Skin, Facts and Figures 
Exhibit 1-11: Oral Cavity and Pharyngeal Cancers, Facts and Figures 
Exhibit 1-12: Ovarian Cancer, Facts and Figures 
Exhibit 1-13: Pancreatic Cancer, Fact and Figures 
Exhibit 1-14: Prostate Cancer, Facts And Figures 
Exhibit 1-15: Thyroid Cancer, Fact and Figures 
Exhibit 1-16: Urinary Bladder Cancer, Fact and Figures 
Exhibit 1-17: Cancer of the Uterine Corpus, Facts and Figures 
Exhibit 1-18: Cancer of the Uterine Cervix, Facts and Figures 

2. U.S. MARKETS FOR ONCOLOGY-RELATED DIAGNOSTIC ULTRASOUND, MINIMALLY INVASIVE BIOPSY, AND TISSUE SCREENING PRODUCTS

2.1 Diagnostic Ultrasound Systems, Market Analysis 
	2.1.1 Technologies 
		2.1.1.1 Doppler Imaging 
		2.1.1.2 Tissue Harmonic Imaging 
		2.1.1.3 Tissue Elastography 
		2.1.1.4 Contrast-Enhanced Ultrasound 
	2.1.2 Procedure Volumes 
	2.1.3 Products 
	2.1.4 Market Forecast 
	2.1.5 Competitive Analysis 
2.2 Minimally Invasive Biopsy Systems, Market Analysis 
	2.2.1 Technologies 
		2.2.1.1 Core Needle/Fine Needle/Multipurpose Tool-Assisted Biopsy 
		2.2.1.2 Vacuum-Assisted Biopsy 
	2.2.2 Procedure Volumes 
	2.2.3 Products 
	2.2.4 Market Forecast 
	2.2.5 Competitive Analysis 
2.3 Tissue Screening, Market Analysis 
	2.3.1 Technologies 
	2.3.2 Procedure Volumes 
	2.3.3 Products 
	2.3.4 Market Forecast 
	2.3.5 Competitive Analysis 

Exhibit 2-1: Oncology-Related Diagnostic Ultrasound, Minimally Invasive Biopsy, and Tissue Screening, Combined Procedure Volumes Forecast, 2012-2017 
Exhibit 2-2: Oncology-Related Diagnostic Ultrasound, Minimally Invasive Biopsy, and Tissue Screening Products, Combined Market  Forecast, 2012-2017 
Exhibit 2-3: Oncology-Related Diagnostic Ultrasound, Procedure Volumes Forecast, 2012-2017 
Exhibit 2-4: 2014, Selected Diagnostic Ultrasound Systems 
Exhibit 2-5: Oncology-Related Diagnostic Ultrasound Systems,  Market Forecast, 2012-2017 
Exhibit 2-6: 2012, Oncology-Related Diagnostic Ultrasound Systems Market, Share by Supplier 
Exhibit 2-7: Minimally Invasive Biopsy, Procedure Volumes Forecast, 2012-2017 
Exhibit 2-8: 2014, Selected Minimally Invasive Biopsy Products 
Exhibit 2-9: Minimally Invasive Biopsy Products, Market Forecast, 2012-2017 
Exhibit 2-10: 2012, Minimally Invasive Biopsy Products Market,  Share by Supplier 
Exhibit 2-11: Tissue Screening, Procedure Volumes Forecast, 2012-2017 
Exhibit 2-12: 2014, Selected Tissue Screening Products 
Exhibit 2-13: Tissue Screening Products, Market Forecast, 2012-2017 
Exhibit 2-14: 2012, Tissue Screening Products Market, Share by Supplier 

3. COMPANY PROFILES

3.1 Analogic Corporation 
3.2 Bard Biopsy Systems/ Bard Peripheral Vascular, Inc./C.R. Bard, Inc 
3.3 Becton, Dickinson and Company 
3.4 CareFusion Corporation 
3.5 Fujifilm SonoSite, Inc./Fujifilm Medical Systems USA, Inc./Fujifilm Holdings America Corporation/Fujifilm 
3.6 GE Healthcare, Inc./General Electric Company 
3.7 Hitachi Aloka Medical America/Hitachi Aloka Medical/Hitachi Medical/Hitachi 
3.8 Hologic, Inc. 
3.9 Mammotome/Devicor Medical Products, Inc. 
3.10 Mindray Medical USA Corporation/Mindray Medical International LTD 
3.11 Philips Healthcare, Inc./Royal Philips NV 
3.12 Qiagen NV 
3.13 Samsung Medison/Samsung Electronics America, Inc./Samsung Electronics Co., LTD/Samsung 
3.14 Siemens Healthcare/Siemens Medical Solutions USA, Inc./Siemens AG 
3.15 Toshiba America Medical Systems, Inc./Toshiba Corporation 

APPENDIX:  COMPANY LISTING


COMPANIES COVERED:

  1. Analogic Corporation
  2. Bard Biopsy Systems/ Bard Peripheral Vascular, Inc./C.R. Bard, Inc.
  3. Becton, Dickinson and Company (BD)
  4. BK Medical/Analogic Corporation
  5. CareFusion Corporation
  6. Cook Medical/Cook, Inc./Cook Group
  7. Encapsule Medical Devices, Inc.
  8. Esaote North America/Esaote SPA
  9. Fujifilm SonoSite, Inc./Fujifilm Medical Systems U.S.A., Inc./Fujifilm Holdings America Corporation/Fujifilm
  10. Fukuda Denshi USA, Inc./Fukuda Denshi Co., LTD
  11. GE Healthcare, Inc./General Electric Company
  12. Hitachi Aloka Medical LTD/Hitachi Medical Corporation/Hitachi LTD
  13. Hologic, Inc.
  14. Mammotome/Devicor Medical Products, Inc.
  15. Mindray Medical USA Corporation/Mindray Medical International LTD
  16. NeedleTech Products, Inc./Theragenics Corporation
  17. NeuroLogica/Samsung Electronics America, Inc./Samsung Electronics Co., LTD/Samsung
  18. Philips Healthcare/Royal Philips NV
  19. Qiagen NV
  20. Ranfac Corporation
  21. Roche Molecular Diagnostics/Roche Molecular Systems, Inc. F. Hoffmann-LaRoche LTD/Roche Group
  22. Samsung Medison/Samsung Electronics America, Inc./Samsung Electronics Co., LTD/Samsung
  23. Scion Medical Technologies LLC
  24. Siemens Healthcare/Siemens Medical Solutions USA, Inc.
  25. Siemens AG
  26. SonoScape Co., LTD
  27. SuperSonic Imagine
  28. Surgical Specialties Corporation
  29. Terason/Teratech Corporation
  30. Toshiba America Medical Systems, Inc./Toshiba Corporation
  31. Ultrasonix Medical/Analogic Corporation
  32. U-Systems/GE Healthcare, Inc./General Electric Company
  33. ZONARE Medical Systems/Mindray Medical International LTD
Contact Us

Need help finding medtech research? Let us help you!